Nucala 100 MG/ML powder vials
Ended Awarded
- Contract number
- SPE2DB26FDQDZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,812
Award facts
- Contract value 100% obligated
- $7,811.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,811.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml powder vials. The contract, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements.
DMS Pharmaceutical Group has demonstrated substantial federal contracting capability, serving as a critical supplier within the military healthcare pharmaceutical supply chain since its registration in the System for Award Management in 2001. The company's portfolio encompasses a comprehensive range of pharmaceuticals including specialty biologics, oncology treatments, vaccines, and medical consumables distributed to military healthcare facilities. The broader PPV-G GEN V contract awarded to DMS Pharmaceutical Group, designated as contract SPE2DR with a $499,999,999 ceiling value and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting recurring medical supply needs across Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FDQDZ?
SPE2DB26FDQDZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FDQDZ worth?
The government has obligated $7,812 on SPE2DB26FDQDZ.
Is contract SPE2DB26FDQDZ an order under another contract?
Yes. SPE2DB26FDQDZ is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB26FDQDZ competed?
The extent of competition for SPE2DB26FDQDZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award